Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy Yu-Yan HwangThomas S. Y. ChanYok-Lam Kwong Original Article 12 April 2022 Pages: 1163 - 1172
Real-world experience of anti-D immunoglobulin in immune thrombocytopenia Kundan MishraSuman KumarVelu Nair Original Article 08 April 2022 Pages: 1173 - 1179
Exploration of the relationship between anemia and iron and zinc deficiencies in children under 5 years of age living in the malaria endemic area of South Kivu/Democratic Republic of Congo Yvette Lufungulo BahatiJoris DelangheJan Philippé Original Article 23 March 2022 Pages: 1181 - 1189
High-flow nasal cannula oxygen in patients with haematological malignancy: a retrospective observational study Simon TetlowRathai AnandanadesanVictoria Metaxa Original Article 08 April 2022 Pages: 1191 - 1199
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant Yi WangTingyu WangShuhua Yi Original Article 18 April 2022 Pages: 1201 - 1210
Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma Kaoru HatanoShin-ichiro FujiwaraYoshinobu Kanda Original Article 11 April 2022 Pages: 1211 - 1216
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma Tan-Huy ChuSung-Hoon JungJe-Jung Lee Original Article 21 April 2022 Pages: 1217 - 1226
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation Doriana GramegnaDiego BertoliGiuseppe Rossi Original Article 05 April 2022 Pages: 1227 - 1237
Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes Shinpei HaradaMasahiro OnozawaTakanori Teshima Original Article 08 March 2022 Pages: 1239 - 1250
The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions Xia BiZachary FrenchLindsay Wilde Original Article 14 March 2022 Pages: 1251 - 1259
Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India Priyanka ChauhanAnshul GuptaSoniya Nityanand Original Article 24 March 2022 Pages: 1261 - 1273
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group Sara PepeElena RossiMassimo Breccia Original Article 22 March 2022 Pages: 1275 - 1282
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation Lijie HanHaiyan ZhangZhongxing Jiang Original Article Open access 25 March 2022 Pages: 1283 - 1294
Acute graft-versus-host disease increase risk and accuracy in prediction model of transplantation-associated thrombotic microangiopathy in patients with myelodysplastic syndrome Ziyan ZhangHong WangYue Han Original Article 31 March 2022 Pages: 1295 - 1309
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis Krischan BraitschAlix SchwarzMareike Verbeek Original Article Open access 01 April 2022 Pages: 1311 - 1319
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation Kevin-James WattebledElodie DrumezDavid Beauvais Original Article 29 March 2022 Pages: 1321 - 1331
Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT Xiao ZhouPeiyao JiangLiping Wan Original Article Open access 09 April 2022 Pages: 1333 - 1342
Management of warm autoimmune hemolytic anemia related to band 3-positive colon carcinoma Yoriko MatsuyamaHiroki HosoiTakashi Sonoki Letter to the Editor 05 November 2021 Pages: 1343 - 1344
Clinical effect of CALR allele burden in patients with essential thrombocythemia Irene BertozziGiacomo BiagettiMaria Luigia Randi Letter to the Editor 06 November 2021 Pages: 1345 - 1346
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm Ronan Le CallochBertrand ArnaudKamel Laribi Letter to the Editor 06 March 2022 Pages: 1347 - 1349
Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report Ting LiuXinxin Cao Letter to the Editor 06 November 2021 Pages: 1351 - 1353
Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis Marko LucijanicIvan KrecakRajko Kusec Letter to the Editor 26 November 2021 Pages: 1355 - 1357
Fever of unknown origin during treatment of mantle-cell lymphoma: is it relapsing disease? Henk-Jan BoitenNick WlazloPieternella J. Lugtenburg Letter to the Editor 26 November 2021 Pages: 1359 - 1360
Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag Ziming JiangXianyong JiangMiao Chen Letter to the Editor 26 November 2021 Pages: 1361 - 1363
Successful cefiderocol therapy of severe infections due to difficult-to-treat Pseudomonas aeruginosa in two allogeneic hematopoietic stem cell transplantation recipients Julien GrasSara Villar-FernandezMatthieu Lafaurie Letter to the Editor 18 January 2022 Pages: 1365 - 1367
Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP Marinella VeltroniFrancesco PegoraroClaudio Favre Letter to the Editor Open access 21 December 2021 Pages: 1369 - 1371
Successful treatment of imatinib-induced periorbital edema with a sodium-glucose cotransporter-2 inhibitor Benjamin Chin-YeeAnargyros Xenocostas Letter to the Editor 02 February 2022 Pages: 1373 - 1374
Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1 África Mellado-GázquezM. Remedios Gómez-NúñezRosario M. Morales-Camacho Letter to the Editor 27 January 2022 Pages: 1375 - 1377
Tirabrutinib maintenance therapy for a patient with high-dose methotrexate-ineligible primary central nervous system lymphoma Tadashi OkamuraHiroki HosoiTakashi Sonoki Letter to the Editor 27 January 2022 Pages: 1379 - 1381
Coexistence of gastric and pulmonary MALT lymphoma and a clonally related, disseminated large B cell lymphoma with conspicuous angiotropism Nao Yoshida-SakaiKensuke OeTakashi Okamura Letter to the Editor 23 February 2022 Pages: 1383 - 1385
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab Ewa RobakDorota Jesionek-KupnickaTadeusz Robak Letter to the Editor 21 February 2022 Pages: 1387 - 1392
Pincered red cells in hereditary spherocytosis Silvia Escribano SerratGonzalo Del Campo BalgueríasFernando Ataúlfo González Fernández Letter to the Editor 02 February 2022 Pages: 1393 - 1394